A University of Chicago team identified a special type of stem cell that heals damaged bowel tissue in mice, a discovery that may have direct application to humans with inflammatory bowel disease. These early findings, made possible with seed funding from the GI Research Foundation, resulted in a recent five-year, $2.5 million grant from the National Institutes of Health to study those cells in humans.

CA CURE - its FY23 campaign - was the biggest in its 60-year history and will continue in the coming year.

Network of high-quality research sites will leverage endoscopy AI platform to expand and accelerate enrollment in gastroenterology clinical trials.

Virgo is first investment for new GI fund.

EndoFresh reveals its novel Disposable Digestive Endoscopy System with full advantages of potential clinical application, patient safety and financial implication, which is approved by the FDA and CE. It is perfect for gastrointestinal endoscopy, effectively helping physicians in ICU, ER, outpatient clinic, GI suite and bed-side treatment, especially during post-pandemic era.

Study further validates TissueCypher(R) as the first and only precision medicine test proven to provide actionable data for predicting patient progression to high-grade dysplasia and esophageal adenocarcinoma

Psychological-based digital therapy supported by strong clinical data from largest randomized clinical trial of its kind

Psychological-based digital therapy supported by strong clinical data from largest randomized clinical trial of its kind

Striving to Meet the "80% in Every Community" Goal

Industry Veterans Join the Developer of the #1 Inflammatory Bowel Disease Mobile App to Expand Product Development and Address Market Needs

Following Explosive U.S. Growth, the Oshi Mobile App for iOS and Android Enters New Regions

Results Demonstrate that GEN-3026 Successfully Met the Primary Study Endpoint of Treating and Preventing Progression of NASH

Granite Peaks GI Recognizes Colon Cancer Awareness Month and Seeks to Raise Awareness

The study compared the effect of ACT-101 to placebo and anti-TNFα the most effective therapy in a model of colitis induced by TNBS.

An unexpected collaboration leads to the discovery of an early predictor of IBD

World experts in Portland share the latest Trials and Studies for Cancer at the LDN 2017 Conference.

The Expert Network© celebrates its newest member, Dr. Jonathan C. Ellis

Andrew W. Litt, MD to join the Board of Digestive Health Services Company

The Expert Network celebrates its newest member, Dr. Parag Chokshi

Same Day Results for 14 of the Most Common Causes of Infectious Diarrhea.

The Expert Network celebrates its newest member, Dr. Steven A. Gorcey